Inventor · disambiguated record
Simon Delagrave
Also filed as: DELAGRAVE SIMON
18 granted patents·27 pending applications·115 citations·filing 2000–2025
92Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS V INC19SANOFI PASTEUR BIOLOGICS LLC6DELAGRAVE SIMON5HERCULES INC3SANOFI PASTEUR LTD2
Top patents by PatentIndex Score
45 records- 0193US11446344B1Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Sep 20, 2022·21 cites·29 claims
- 0291US11166996B2Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Nov 9, 2021·12 cites·66 claims
- 0390US6498026B2Variant galactose oxidase, nucleic acid encoding same, and methods of using sameHERCULES INC·Filed 2001·Granted Dec 24, 2002·47 cites·7 claims
- 0486US10363304B2Purification of herpes virusSANOFI PASTEUR BIOLOGICS LLC·Filed 2016·Granted Jul 30, 2019·3 cites·18 claims
- 0585US9365832B2Purification of herpes virusSANOFI PASTEUR BIOLOGICS LLC·Filed 2013·Granted Jun 14, 2016·5 cites·16 claims
- 0680US6479262B1Solid phase enzymatic assembly of polynucleotidesHERCULES INC·Filed 2000·Granted Nov 12, 2002·14 cites·35 claims
- 0779US8877492B2Compositions and methods for the production of alpha-herpesvirusesDELAGRAVE SIMON·Filed 2009·Granted Nov 4, 2014·6 cites·19 claims
- 0877US6635453B2Methods for the enzymatic assembly of polynucleotides and identification of polynucleotides having desired characteristicsHERCULES INC·Filed 2001·Granted Oct 21, 2003·7 cites·26 claims
- 0971US12214035B2Herpesvirus compositions and related methodsSANOFI PASTEUR LTD·Filed 2022·Granted Feb 4, 2025·0 cites·16 claims
- 1070US2022362315A1Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1168US11224650B2Purification of herpes virusSANOFI PASTEUR BIOLOGICS LLC·Filed 2019·Granted Jan 18, 2022·0 cites·17 claims
- 1268US2025059559A1Surface-modified viral particles and modular viral particlesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1366US2022372519A1In vitro assembly of anellovirus capsids enclosing rnaFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 1464US2024415978A1Anellovectors for delivery of effectors to the central nervous systemFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 1563US2025257368A1In vitro assembly of anellovirus capsids enclosing rnaFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 1663US2025213725A1Novel anelloviridae family vector compositions and methodsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 1761US11260123B2Herpesvirus compositions and related methodsSANOFI PASTEUR LTD·Filed 2013·Granted Mar 1, 2022·0 cites·31 claims
- 1861USRE47768ECompositions and methods for the production of alpha-herpesvirusesSANOFI PASTEUR BIOLOGICS LLC·Filed 2009·Granted Dec 17, 2019·0 cites·27 claims
- 1961US2024327867A1Anellovirus constructs comprising recombination sites and cross-packaging of anellovector particles and genetic elementsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2024·Application pending·0 cites
- 2061US2023048858A1Anellosomes for delivering secreted therapeutic modalitiesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 2160US8486417B2Recombinant bicistronic Flavivirus vectorsDELAGRAVE SIMON·Filed 2008·Granted Jul 16, 2013·0 cites·17 claims
- 2260US2024408241A1Novel anellovector compositions and methodsFLAGSHIP PIONEERING INNOVATION V INC·Filed 2022·Application pending·0 cites
- 2360US2025320465A1Compositions comprising modified anellovirus capsid proteins and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 2459US9228203B2Recombinant bicistronic flavivirus vectorsSANOFI PASTEUR BIOLOGICS LLC·Filed 2013·Granted Jan 5, 2016·0 cites·12 claims
- 2557US8158588B2Loop-variant PDZ domains as biotherapeutics, diagnostics and research reagentsDELAGRAVE SIMON·Filed 2006·Granted Apr 17, 2012·0 cites·2 claims
- 2656US2023227849A1Methods of identifying and characterizing anelloviruses and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 2755US2024123083A1Hybrid aav-anellovectorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 2855US2023340527A1Baculovirus expression systemsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 2952US2012171122A1Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research ReagentsDELAGRAVE SIMON·Filed 2012·Application pending·0 cites
- 3051US8591916B2Flavivirus vaccine vector against influenza virusDELAGRAVE SIMON·Filed 2008·Granted Nov 26, 2013·0 cites·19 claims
- 3151US2023348933A1Tandem anellovirus constructsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 3250US11286465B2ICP0-mediated enhanced expression systemSANOFI PASTEUR BIOLOGIES LLC·Filed 2018·Granted Mar 29, 2022·0 cites·7 claims
- 3350US2022042042A1Anellosomes and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 3450US2024000914A1Chicken anemia virus (cav)-based vectorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 3549US10208292B2ICP0-mediated enhanced expression systemSANOFI PASTEUR BIOLOGICS LLC·Filed 2016·Granted Feb 19, 2019·0 cites·16 claims
- 3649US2004067534A1Methods of preparing improved agents by coevolutionFiled 2003·Application pending·0 cites
- 3748US2022040117A1Anellosomes for delivering intracellular therapeutic modalitiesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 3848US2022073950A1Anellosomes for delivering protein replacement therapeutic modalitiesFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Application pending·0 cites
- 3947US2007218001A1Biotherapeutics, Diagnostics and Research ReagentsBIOTECH STUDIO LLC·Filed 2005·Application pending·0 cites
- 4044US2003089472A1Laccase activity enhancers for pulp bleachingFiled 2001·Application pending·0 cites
- 4143US2003047295A1Bio-bleaching of pulp using laccase, mediator, and chain transfer agentFiled 2001·Application pending·0 cites
- 4243US2003096394A1Laccase activity enhancersFiled 2001·Application pending·0 cites
- 4343US2003094251A1Enhancing laccase activity using pro-oxidants and pro-degradantsFiled 2001·Application pending·0 cites
- 4443US2003087254A1Methods for the preparation of polynucleotide libraries and identification of library members having desired characteristicsFiled 2002·Application pending·0 cites
- 4542US2003049619A1Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotidesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Simon Delagrave files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →